Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

Share Price is delayed by 15 minutes
Get Live Data
85.20    -5.90 (-6.48%)
Bid:
85.50
Ask:
86.00
Spread: 0.50 (0.585%)
Market Cap: £591.69m
DATA Live PriceLast checked at - London Stock Exchange

Intraday GlobalData Share Chart

Board changes

19 Jan 2026 07:00

RNS Number : 3175P
GlobalData PLC
19 January 2026
 

19 January 2026

 

 

GlobalData Plc (GlobalData; the Company)Board changes

 

GlobalData Plc, a leading data, insights, and technology company, is pleased to announce the appointment of Rachel Higham as an independent non-executive director with effect from 20 January 2026.

Rachel brings to the board more than 30 years of experience in the information technology sector, having held senior roles at Marks & Spencer, WPP, BT and Vodafone.

In accordance with Schedule 2(g) of the AIM Rules for Companies, Rachel Higham is 51 years old. In the last 5 years she has been, and still is, a director at RHigham Consulting Limited and director and trustee at Macmillan Cancer Support. There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

This appointment is part of wider changes being announced with respect to the board's independent non-executive directorships. Both Annette Barnes and Andrew Day will not offer themselves for re-election as a director at the 2026 Annual General Meeting given they would, at that time, have served on the board for more than nine years from the date of their first appointment. Annette and Andrew will resign from office prior to the Company announcing its 2025 full year results on 2 March 2026.

Rachel is being appointed to succeed Andrew Day and a further appointment to succeed Annette Barnes is expected to be announced shortly. 

 

Mike Danson, Chief Executive Officer of GlobalData, commented:

"On behalf of the board, I would like to thank Annette and Andrew for their exceptional support and guidance over the last nine years during which time GlobalData has evolved into a globally recognised market leader. We wish them all the best for the future."

"I am also delighted to welcome Rachel to the GlobalData team. Rachel will bring a wealth of knowledge and expertise to our board both from her experiences within the technology sector, but also from her focus and passion for data and innovation.''

 

-ENDS-

 

 

ENQUIRIES

GlobalData Plc

0207 936 6400

Mike Danson, Chief Executive Officer

Graham Lilley, Chief Financial Officer

J.P. Morgan Cazenove (Nomad, Joint Broker)

0203 493 8000

Bill Hutchings

Mose Adigun

Panmure Liberum (Joint Broker)

0203 100 2000

Rupert Dearden

James Sinclair-Ford

 

Investec Bank plc (Joint Broker)

Henry Reast

0207 597 5970

Virginia Bull

FTI Consulting (Financial PR)

0203 727 1000

Edward Bridges

globaldata@fticonsulting.com

Dwight Burden

Emma Hall

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUQWGUPQPUQ
Date   Source Headline
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSFull Year Results
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 202511:49 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSProposed move to the Main Market
14th Jan 20257:00 amRNSTrading Statement
13th Jan 20257:00 amRNSTransaction in Own Shares & Buyback Completion
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSAcquisition of Deallus
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSNew £340m debt financing facilities
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.